Moneycontrol
Close Ad
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Glenmark Pharma

Glenmark Pharma

BSE: 532296|NSE: GLENMARK|ISIN: INE935A01035|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 16, 16:00
551.60
-13.3 (-2.35%)
VOLUME 34,213
LIVE
NSE
Jul 16, 15:58
551.95
-13.35 (-2.36%)
VOLUME 595,956
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Quarterly Results of Glenmark Pharma

------------------- in Rs. Cr. -------------------
Mar '18 Dec '17 Sep '17 Jun '17 Mar '17
Net Sales/Income from operations 1,506.33 1,459.25 1,619.55 1,510.93 1,938.56
Other Operating Income 161.42 97.30 40.26 36.85 126.53
Total Income From Operations 1,667.75 1,556.55 1,659.81 1,547.78 2,065.09
EXPENDITURE
Consumption of Raw Materials 531.25 522.47 484.82 500.02 547.88
Purchase of Traded Goods 63.27 89.20 66.41 69.31 56.03
Increase/Decrease in Stocks 34.73 -30.45 58.50 -10.93 0.10
Power & Fuel -- -- -- -- --
Employees Cost 232.33 255.40 326.43 207.77 221.13
Depreciation 29.82 29.55 28.89 29.94 27.32
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 475.85 453.14 326.20 428.68 567.85
P/L Before Other Inc. , Int., Excpt. Items & Tax 300.49 237.24 368.56 323.00 644.78
Other Income 44.30 37.23 56.30 42.59 -50.25
P/L Before Int., Excpt. Items & Tax 344.79 274.48 424.87 365.59 594.53
Interest 50.72 47.00 47.44 45.74 49.72
P/L Before Exceptional Items & Tax 294.07 227.48 377.43 319.85 544.81
Exceptional Items -- -- -- -- -236.45
P/L Before Tax 294.07 227.48 377.43 319.85 308.36
Tax 72.56 33.36 49.55 49.01 -48.70
P/L After Tax from Ordinary Activities 221.51 194.12 327.88 270.84 357.06
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 221.51 194.12 327.88 270.84 357.06
Equity Share Capital 28.22 28.22 28.22 28.22 28.22
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 7.85 6.88 11.62 9.60 12.65
Diluted EPS 7.85 6.88 11.62 9.60 12.65
EPS After Extra Ordinary
Basic EPS 7.85 6.88 11.62 9.60 12.65
Diluted EPS 7.85 6.88 11.62 9.60 12.65
Public Share Holding
No Of Shares (Crores) -- -- -- -- --
Share Holding (%) -- -- -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
Notes
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for glenmarkpharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.